Journal of Medical Genetics · 2022 · 12 citations · 5 references
Life SciencesGeneticsMolecular GeneticsHuman GeneticsMedical GeneticsNeurogeneticsGenetic DisordersGenetic Risk AssessmentGenetic SyndromesNeurodevelopmental DisordersRare Disease GeneticsRare Disease GenomicsHuman Health EffectsNeurodegenerative Disease CasesNeurodegenerative Disease EpidemiologyRecruitment Decision SupportReplication In Diverse CohortsValidation In Diverse Cohorts
FMR1 premutation cytosine-guanine-guanine repeat expansion alleles are relatively common mutations in the general population that are associated with a neurodegenerative disease (fragile X-associated tremor/ataxia syndrome), reproductive health problems and potentially a wide range of additional mental and general health conditions that are not yet well-characterised. The International Fragile X Premutation Registry (IFXPR) was developed to facilitate and encourage research to better understand the FMR1 premutation and its impact on human health, to facilitate clinical trial readiness by identifying and characterising diverse cohorts of individuals interested in study participation, and to build community and collaboration among carriers, family members, researchers and clinicians around the world. Here, we describe the development and content of the IFXPR, characterise its first 747 registrants from 32 countries and invite investigators to apply for recruitment support for their project(s). With larger numbers, increased diversity and potentially the future clinical characterisation of registrants, the IFXPR will contribute to a more comprehensive and accurate understanding of the fragile X premutation in human health and support treatment studies.
5
Ronald A.M. Buijsen, Jenny A. Visser, P. Kramer et al. · Human Reproduction · 2015 · 103 citations · Full text
Fragile X Premutation Associated Conditions (FXPAC)
Kirsten Johnson, Jonathan Herring, J. Richstein · Frontiers in Pediatrics · 2020 · 42 citations · Full text
Medicine, Gynecology, Psychiatry +5